Chicago Capital LLC Has $2.45 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Chicago Capital LLC boosted its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 97.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,941 shares of the conglomerate's stock after purchasing an additional 5,895 shares during the period. Chicago Capital LLC's holdings in Danaher were worth $2,448,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in DHR. Heck Capital Advisors LLC bought a new stake in Danaher in the fourth quarter valued at $27,000. Strategic Financial Concepts LLC acquired a new stake in shares of Danaher in the 4th quarter valued at $31,000. Rialto Wealth Management LLC acquired a new stake in shares of Danaher in the 4th quarter valued at $34,000. Hurley Capital LLC bought a new stake in shares of Danaher in the 4th quarter worth about $34,000. Finally, Ameriflex Group Inc. acquired a new stake in shares of Danaher during the 4th quarter worth about $38,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on DHR shares. Robert W. Baird dropped their price objective on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Guggenheim reaffirmed a "buy" rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. HSBC cut their price objective on Danaher from $270.00 to $240.00 in a research report on Friday, April 25th. The Goldman Sachs Group decreased their target price on Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a report on Wednesday, April 23rd. Finally, TD Cowen lifted their price target on Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $248.17.

Danaher Stock Down 2.6%

Shares of NYSE DHR traded down $5.30 during trading hours on Tuesday, hitting $195.81. The company had a trading volume of 2,968,631 shares, compared to its average volume of 3,487,351. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm's 50 day moving average is $193.35 and its 200-day moving average is $210.53. The stock has a market capitalization of $140.13 billion, a P/E ratio of 37.08, a price-to-earnings-growth ratio of 2.66 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The company had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.58 billion. On average, analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.65%. Danaher's dividend payout ratio (DPR) is 24.85%.

Insider Buying and Selling at Danaher

In related news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares of the company's stock, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the sale, the chairman now directly owns 3,105,808 shares of the company's stock, valued at $611,036,665.92. This represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company's stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.